Pune: Mylab Discovery Solutions has launched ‘PathoDetect HPV Detection Test’, a real-time PCR based screening solution to detect high-risk types of HPV in individuals. The company also plans to introduce an extension of this kit which can simultaneously detect up to 15 high-risk along with discrimination of HPV 16 & 18 covering more than 95 per cent cases of cervical cancers.
Approved by regulatory authority, the test detects and discriminates the presence of high-risk HPV strains including 16 and 18 which cause most of the cervical cancers. One of the benefits of this test is that a woman with a positive (High Risk HPV) cervical screening result may be advised for further follow-up tests at shorter intervals. A negative test for the high-risk HPV genotypes would mean a longer interval between the next screening test.
Speaking about the launch, Hasmukh Rawal, Co-founder and Managing Director, Mylab, said “Cervical cancer is preventable; hence, with effective screening, early diagnosis of HPV and timely intervention by gynaecologists, it can often be treated successfully. We are confident that our HPV Detection test will help to protect women from the potential harms of undetected and untreated cervical disease by effectively and accurately detecting the virus that causes nearly all cervical cancers.”
The test allows high throughput testing that is accurate, automated, simple, and reliable with Mylab Compact platform series automations within two hours without any high-end infrastructure or technical expertise requirements.